EUVIMEDEUVIMED entdecken
Crossref

Molecular evaluation of biosynthesized selenium nanoparticles and their effect on oral squamous cell carcinoma

R. T. Al-Muswie, M. N. Abdulsayed, D. A. Alghezi, B. A. Ghyadh, A. J. Alfahdawi

The Ukrainian Biochemical Journal · 20.04.2026 · 98 (2) · 85-95

DOI: 10.15407/ubj98.02.085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Ukrainian Biochemical Journal, online erschienen am 20.04.2026. Verfasst von R. T. Al-Muswie und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a predominant cause of mortality globally, and the suboptimal effectiveness of existing­ therapeutic modalities has catalyzed the exploration of novel treatment approaches. Nanomaterials, specifically selenium nanoparticles (SeNPs), have exhibited encouraging anticancer activity. This investigation aimed to evaluate the human oral squamous cell carcinoma (OSCC) cells viability and expression of prolifera­tion and apoptosis molecular markers under treatment with SeNPs. Selenium nanoparticles were synthesized with the use of Lactobacillus plantarum cultured in a medium containing selenium dioxide. The methods of energy-dispersive X-ray, scanning electron and atomic force microscopy were used to determine the SeNPs composition and three-dimensional images. MTT viability assay and qRT-PCR analysis of cyclin D1 and Bax gene expression were applied. OSCC cells were treated with SeNPs in a range of 25–200 µg/ml for 24 h. It was demonstrated that SeNPs induced a dose-dependent inhibition of cell viability with IC50 value of 97 μg/ml. At lower concentrations (25–50 µg/ml) SeNPs transiently suppressed Bax and elevated Cyclin D1 expression­, indicating the adaptive proliferative response. At higher concentrations (100–200 µg/ml), SeNPs induced apoptotic pathways and G1-phase cell cycle arrest, significantly upregulating Bax and downregulating­ Cyclin D1 expression. These findings underscore the Selenium nanoparticles potential as nanotherapeutic agents for OSCC treatment. Keywords: Bax, cyclin D, oral squamous cell carcinoma, selenium nanoparticles

Zitieren

APA

Al-Muswie, R. T., Abdulsayed, M. N., Alghezi, D. A., Ghyadh, B. A., & Alfahdawi, A. J. (2026). Molecular evaluation of biosynthesized selenium nanoparticles and their effect on oral squamous cell carcinoma. The Ukrainian Biochemical Journal, 98(2), 85-95. https://doi.org/10.15407/ubj98.02.085

Vancouver

Al-Muswie RT, Abdulsayed MN, Alghezi DA, Ghyadh BA, Alfahdawi AJ. Molecular evaluation of biosynthesized selenium nanoparticles and their effect on oral squamous cell carcinoma. The Ukrainian Biochemical Journal. 2026;98(2):85-95. doi:10.15407/ubj98.02.085

BibTeX
@article{AlMuswie2026,
  author = {Al-Muswie, R. T. and Abdulsayed, M. N. and Alghezi, D. A. and Ghyadh, B. A. and Alfahdawi, A. J.},
  title = {Molecular evaluation of biosynthesized selenium nanoparticles and their effect on oral squamous cell carcinoma},
  journal = {The Ukrainian Biochemical Journal},
  year = {2026},
  volume = {98},
  number = {2},
  pages = {85--95},
  doi = {10.15407/ubj98.02.085}
}
Kostenlos starten →